|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.200 GBX | 0.00% |
|
-0.80% | -37.06% |
| 05-05 | Shield Therapeutics plc, Q1 2026 Sales/ Trading Statement Call, May 05, 2026 | |
| 05-01 | EARNINGS AND TRADING: ProService Building Services lowers outlook | AN |
Company Valuation: Shield Therapeutics plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 96.06 | 18.29 | 52.4 | 21.12 | 104.6 | 66.24 | - | - |
| Change | - | -80.96% | 186.53% | -59.7% | 395.31% | -36.66% | - | - |
| Enterprise Value (EV) 1 | 84.1 | 18.29 | 57.43 | 36.04 | 118.4 | 84.29 | 77.19 | 72.85 |
| Change | - | -78.26% | 214.05% | -37.25% | 228.51% | -28.8% | -8.42% | -5.63% |
| P/E | -4.94x | -0.41x | -1.68x | -1.2x | -6.62x | -282x | 8.4x | 10.7x |
| PBR | 2.34x | - | 4.37x | -27.6x | -9.4x | -6.48x | -7.01x | -21x |
| PEG | - | -0x | 0x | 0x | 0.2x | 2.9x | -0x | -0.5x |
| Capitalization / Revenue | 63.2x | 4.09x | 5.01x | 0.87x | 2.83x | 1.19x | 0.88x | 0.78x |
| EV / Revenue | 55.4x | 4.09x | 5.49x | 1.49x | 3.2x | 1.51x | 1.03x | 0.86x |
| EV / EBITDA | -4.74x | -0.78x | -2.38x | -2.23x | -17.8x | 21.2x | 7.41x | 3.91x |
| EV / EBIT | -4.22x | -0.71x | -2.29x | -2.09x | -15.8x | 27x | 8.07x | 6.77x |
| EV / FCF | -4.92x | - | -1.79x | -5.22x | -43.2x | 30.5x | 13x | 9.15x |
| FCF Yield | -20.3% | - | -55.8% | -19.2% | -2.32% | 3.27% | 7.69% | 10.9% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.09 | -0.17 | -0.04 | -0.0226 | -0.0149 | -0.00022 | 0.00738 | 0.0058 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1.519 | 4.467 | 10.46 | 24.23 | 36.99 | 55.68 | 75.12 | 85.07 |
| EBITDA 1 | -17.74 | -23.34 | -24.18 | -16.15 | -6.65 | 3.982 | 10.42 | 18.62 |
| EBIT 1 | -19.95 | -25.71 | -25.04 | -17.22 | -7.479 | 3.122 | 9.567 | 10.76 |
| Net income 1 | -19.34 | -40.44 | -26.6 | -20.46 | -13.14 | -0.0745 | 7.86 | 6.165 |
| Net Debt 1 | -11.96 | - | 5.032 | 14.92 | 13.79 | 18.05 | 10.95 | 6.605 |
| Reference price 2 | 0.4450 | 0.0705 | 0.0670 | 0.0270 | 0.0985 | 0.0620 | 0.0620 | 0.0620 |
| Nbr of stocks (in thousands) | 215,874 | 259,388 | 782,056 | 782,056 | 1,061,803 | 1,068,418 | - | - |
| Announcement Date | 6/30/22 | 4/27/23 | 5/10/24 | 4/24/25 | 4/9/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -281.82x | 1.51x | 21.17x | - | 88.9M | |
| 17.76x | 3.85x | 10.09x | 0.58% | 68.38B | |
| 25.64x | 5.3x | 15.59x | 0.61% | 51.69B | |
| 34.55x | 11.7x | 22.35x | -.--% | 42.1B | |
| -46.16x | 3.26x | 9.62x | 3.31% | 41.11B | |
| 24.47x | 3.57x | 11.94x | -.--% | 29.52B | |
| -7.13x | 10.08x | -6.19x | -.--% | 23.6B | |
| 77.55x | - | - | -.--% | 23.1B | |
| 64.32x | 6.31x | 43.41x | -.--% | 20.54B | |
| 24.47x | 5.19x | 13.62x | -.--% | 16.53B | |
| Average | -6.63x | 5.64x | 15.73x | 0.5% | 31.67B | |
| Weighted average by Cap. | 19.40x | 5.87x | 14.16x | 0.65% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- STX Stock
- Valuation Shield Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
